ATH.AX

Alterity Therapeutics Limited ATH.AX

ATH.AX
Alterity Therapeutics Limited IMU.AX
Imugene Limited RCE.AX
Recce Pharmaceuticals Ltd EZZ.AX
EZZ Life Science Holdings Limited SPL.AX
Starpharma Holdings Limited ALA.AX
Arovella Therapeutics Limited ACW.AX
Actinogen Medical Limited RAD.AX
Radiopharm Theranostics Limited BIO.AX
Biome Australia Limited ILA.AX
Island Pharmaceuticals Limited

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ATH.AX IMU.AX RCE.AX EZZ.AX SPL.AX ALA.AX ACW.AX RAD.AX BIO.AX ILA.AX
6M 33.33 % -54.75 % 45.61 % 71.52 % 187.88 % 21.79 % 3.45 % 76.19 % 4.49 % 124.24 %
YTD 33.33 % -69.92 % -15.31 % -9.06 % 159.09 % -44.12 % 15.38 % 54.17 % -22.50 % 124.24 %
1Y 300.00 % -76.05 % -23.85 % -32.42 % 200.00 % -50.00 % 11.11 % 42.31 % -30.60 % 111.43 %
3Y -7.69 % -93.08 % -36.49 % 788.52 % -55.81 % 227.59 % -72.46 % -75.44 % 511.84 % 134.38 %
5Y -75.00 % -78.61 % -60.85 % 133.62 % -80.87 % 131.71 % 29.25 % -89.63 % 287.50 % -24.10 %
10Y -90.40 % 31.89 % 39.71 % 133.62 % -60.42 % -82.24 % -48.71 % -89.63 % 287.50 % -24.10 %
From the beginning -97.60 % -99.52 % 39.71 % 133.62 % -66.47 % -97.10 % -95.44 % -89.63 % 287.50 % -24.10 %

Dividend

EZZ Life Science Holdings Limited